L.C. Steggink

research physician

L.C. Steggink
E-mail:
l.c.steggink umcg.nl

Research

  1. 2020
  2. Steenbruggen, T. G., Steggink, L. C., Seynaeve, C. M., van der Hoeven, J. J. M., Hooning, M. J., Jager, A., Konings, I. R., Kroep, J. R., Smit, W. M., Tjan-Heijnen, V. C. G., van der Wall, E., Bins, A. D., Linn, S. C., Schaapveld, M., Jacobse, J. N., van Leeuwen, F. E., Schröder, C. P., van Tinteren, H., de Vries, E. G. E., ... Gietema, J. A. (2020). High-Dose Chemotherapy With Hematopoietic Stem Cell Transplant in Patients With High-Risk Breast Cancer and 4 or More Involved Axillary Lymph Nodes 20-Year Follow-up of a Phase 3 Randomized Clinical Trial: 20-Year Follow-up of a Phase 3 Randomized Clinical Trial. JAMA oncology, 6(4), 528-534. https://doi.org/10.1001/jamaoncol.2019.6276
  3. Jacobse, J. N., Steggink, L., Sonke, G. S., Schaapveld, M., Hummel, Y. M., Steenbruggen, T. G., Lefrandt, J., Nuver, J., Crijns, A., Aleman, B. M. P., Gietema, J. A., & van Leeuwen, F. E. (2020). Myocardial dysfunction in long-term breast cancer survivors treated at ages 40-50years. European Journal of Heart Failure, 22(2), 338-346. https://doi.org/10.1002/ejhf.1610
  4. 2019
  5. 2018
  6. Steenbruggen, T. G., Steggink, L., Seynaeve, C. M., van der Hoeven, JJM., Hooning, M. J., Jager, A., Konings, IR., Kroep, J. R., Smit, WM., Tjan-Heijnen, V. C. G., van der Wall, E., Bins, AD., Linn, SC., Schaapveld, M., van Leeuwen, FE., Schröder, C., van Tinteren, H., de Vries, E. G. E., Sonke, G. S., & Gietema, J. A. (2018). High-dose chemotherapy (HDCT) with hematopoietic stem cell transplantation (HSCT) in high-risk breast cancer (BC) patients with ≥4 involved axillary lymph nodes (ALN): 20-year follow-up of a randomized phase 3 study, Proffered paper (oral presentation) 187O. Abstract from European Society for Medical Oncology 2018 meeting, .
  7. 2017
  8. 2015
  9. 2013

ID: 503168